Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro

British Journal of Pharmacology

Volumn 151, Issue 2, 2007, Pages 195-205

  Silva, C L M ^a,b   Tamura, E K ^a   Macedo, S M D ^a   Cecon, E ^a   Bueno Alves, L ^a   Farsky, S H P ^a   Ferreira, Z S ^a   Markus, R P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ATP; Bradykinin; Calcium; Confocal microscopy; Endothelial cell; Histamine; Intravital microscopy; Melatonin; Nitric oxide

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ACETYLSEROTONIN METHYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; ARALKYLAMINE ACETYLTRANSFERASE; BRADYKININ; CALCIUM; CARBACHOL; HISTAMINE; LUZINDOLE; MELATONIN; MELATONIN 2 RECEPTOR; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME SYNTHESIS; FLUOROMETRY; IN VITRO STUDY; MALE; MOBILIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; VASODILATATION;

ACETYLSEROTONIN N-METHYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; ANIMALS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; BLOOD FLOW VELOCITY; CALCIUM; CARBACHOL; CELLS, CULTURED; ENDOTHELIAL CELLS; FLUOROMETRY; GENE EXPRESSION; HISTAMINE; MALE; MELATONIN; MESENTERIC ARTERIES; MICROSCOPY, CONFOCAL; MICROSCOPY, VIDEO; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTOR, MELATONIN, MT2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASODILATION;

EID: 34248583663     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707225     Document Type: Article

References (61)

1. Balcerczyk A, Soszynski M, Bartosz G (2005). On the specificity of 4-amino-5-methylamino-2′,7′-difluorofluorescein as a probe for nitric oxide. Free Radic Biol Med 39: 327-335.
2. Bauer PM, Fulton D, Boo YC, Sorescu GP, Kemp BE, Jo H et al. (2003). Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem 278: 14841-14849.
3. 3H-melatonin to calmodulin. Life Sci 53: 201-207.
4. Beutelspacher SC, Tan PH, McClure MO, Larkin DF, Lechler RI, George AJ (2006). Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 6: 1320-1330.
5. Boutin JA, Audinot V, Ferry G, Delagrange P (2005). Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 26: 412-419.
6. Burnstock G (2006). Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27: 166-176.
7. 2 receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Br J Pharmacol 136: 847-856.
8. Capsoni S, Viswanathan M, Oliveira AM, Saavedra JM (1994). Characterization of melatonin receptors and signal transduction system in rat arteries forming the Circle of Willis. Endocrinology 153: 373-378.
9. Castro AF, Amorena C, Muller A, Ottaviano G, Tellez-Inon MT, Taquini AC (1998). Extracellular ATP and bradykinin increase cGMP in vascular endothelial cells via activation of PKC. Am J Physiol 275: C113-C119.
10. SOC. Cell Calcium 33: 323-336.
11. Cocks TM (1996). Endothelium-dependent vasodilator mechanisms. In: Garland CJ and Angus JA (eds). Pharmacology of Vascular Smooth Muscle. Oxford University Press: Oxford, pp 233-251.
12. de Almeida-Paula LD, Costa-Lotufo LV, Silva Ferreira Z, Monteiro AE, Isoldi MC, Godinho RO et al. (2005). Melatonin modulates rat myotube-acetylcholine receptors by inhibiting calmodulin. Eur J Pharmacol 525: 24-31.
13. 2 melatonin receptors in mammals. Endocrine 27: 101-110.
14. Dudzinski DM, Igarashi J, Greif D, Michel T (2006). The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 46: 235-276.
15. Elherik K, Khan F, McLaren M, Kennedy G, Belch JJ (2002). Circadian variation in vascular tone and endothelial function in normal males. Clin Sci (London) 102: 547-552.
16. Ferreira ZS, Cipolla-Neto J, Markus RP (1994). Presence of P2-purinoceptors in the rat pineal gland. Br J Pharmacol 112: 107-110.
17. Fernandes PACM, Cecon E, Markus RP, Ferreira ZS (2006). Effect of TNF-α on the melatonin synthetic pathway in the rat pineal gland: basis for a 'feedback' of the immune response on circadian timing. J Pineal Res 41: 344-350.
18. Fleming I, Busse R (2003). Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 284: R1-R12.
19. Frid MG, Aldashev AA, Crossno JT, Jorgensen JM, Kale VA, Stenmark KR (2004). Yin and Yang of an endothelial cell: from normal to the extreme in growth, secretion, and transdifferentiation capabilities. Paediatric Resp Rev 5: S253-S257.
20. + channels and endothelial factors. Br J Pharmacol 123: 1533-1543.
21. 2+ homeostasis and formation of cGMP and prostacyclin. Am J Physiol 265: C1620-C1629.
22. Govers R, Rabelink TJ (2001). Cellular regulation of endothelial nitric oxide synthase. Am J Physiol 280: F193-F206.
23. Hatakeyama T, Pappas PJ, Hobson II RW, Boric MP, Sessa WC, Duran WN (2006). Endothelial nitric oxide synthase regulates microvascular hypermeability in vivo. J Physiol 574: 275-281.
24. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM et al. (1997). International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49: 253-278.
25. Kimura C, Oike M, Ohnaka K, Nose Y, Ito Y (2004). Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cell: a comparative study. J Physiol 554: 721-730.
26. Kojima H, Urano Y, Kikuchi K, Higuchi T, Hirata Y, Nagano T (1999). Fluorescent indicators for imaging nitric oxide production. Angew Chem Int Ed Engl 38: 3209-3212.
27. Kone BC, Kuncewicz T, Zhang W, Yu ZY (2003). Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol 285: F178-F190.
28. Kunapuli SP, Daniel JL (1998). P2 receptor subtypes in the cardiovascular system. Biochem J 336: 513-523.
29. Kvetnoy IM (1999). Extrapineal melatonin: location and role within diffuse neuroendocrine system. Histochem J 31: 1-12.
30. Lang D, Bell JP, Bayraktutan U, Small GR, Shah AM, Lewis MJ (1999). Phenotypic changes in rat and guinea pig coronary microvascular endothelium after culture: loss of nitric oxide synthase activity. Cardiovasc Res 42: 794-804.
31. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL (2005). International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57: 27-77.
32. Léon J, Escames G, Rodriguez MI, Lopez LC, Tapias V, Entrena A et al. (2006). Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 98: 2023-2033.
33. Lopes C, de Lyra JL, Markus RP, Mariano M (1997). Circadian rhythm in experimental granulomatous inflammation is modulated by melatonin. J Pineal Res 23: 72-78.
34. Lotufo CMC, Lopes C, Dubocovich ML, Farsky SHP, Markus RP (2001). Melatonin and N-acetylserotonin inhibit leukocyte rolling and adherence to ratmicrocirculation. Eur J Pharmacol 430: 351-357.
35. 4. Eur J Pharmacol 534: 258-263.
36. i responses. Am J Physiol 281: H1759-H1766.
37. 2 melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 302: 1295-1302.
38. Michell BJ, Harris MB, Chen ZP, Ju H, Venema VJ, Blackstone MA et al. (2002). Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem 277: 42344-42351.
39. 2+ signals in primary cultures of cardiac microvascular endothelial cells. Microvasc Res 61: 240-252.
40. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A et al. (1998). Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99-107.
41. Nakatsubo N, Kojima H, Kikuchi K, Nagoshi H, Hirata Y, Maeda D et al. (1998). Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett 427: 263-266.
42. Noda Y, Mori A, Liburdy R, Packer L (1999). Melatonin and its precursor scavenger nitric oxide. J Pineal Res 27: 159-163.
43. 2+ concentration in aortic endothelial cells. Eur J Pharmacol 319: 291-298.
44. Pontes GN, Cardoso EC, Carneiro-Sampaio MM, Markus RP (2006). Injury switches melatonin production source from endocrine (pineal) to paracrine (phagocytes) - melatonin in human colostrum and colostrum phagocytes. J Pineal Res 41: 136-141.
45. Pozo D, Reiter RJ, Calvo JR, Guerrero JM (1997). Inhibition of cerebellar nitric oxide synthase and cGMP production by melatonin via complex formation with calmodulin. J Cell Biochem 65: 430-442.
46. Ramirez AN, Kunze DL (2002). P2X purinergic receptor channel expression and functional in bovine aortic endothelium. Am J Physiol 282: H2106-H2116.
47. Romero MP, Garcia-Perganeda A, Guerrero JM, Osuna C (1998). Membrane-bound calmodulin in Xenopus laevis oocytes as a novel binding site for melatonin. FASEB J 12: 1401-1408.
48. Schaefer U, Scneider A, Rixen D, Neugebauer E (1998). Neutrophil adhesion to histamine stimulated cultured endothelial cells is primarily mediated via activation of phospholipase C and nitric oxide synthase isozymes. Inflamm Res 47: 256-264.
49. Schubert W, Frank PG, Woodman SE, Hyogo H, Cohen DE, Chow CW et al. (2002). Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 277: 40091-40098.
50. Seltzer A, Viswanathan M, Saavedra JM (1992). Melatonin-binding sites in brain and caudal arteries of the female rat during the estrous cycle and after estrogen administration. Endocrinology 130: 1896-1902.
51. Simmonneaux V, Ribelayga C (2003). Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 55: 325-395.
52. Stevens T, Rosenberg R, Aird W, Quertermous T, Johnson FL, Garcia JG et al. (2001). NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol 281: C1422-C1433.
53. Tamura EK, Silva CLM, Markus RP (2006). Melatonin inhibits endothelial nitric oxide production in vitro. J Pineal Res 41: 267-274.
54. Vanecek J (1998). Cellular mechanisms of melatonin action. Physiol Rev 78: 687-721.
55. Venema RC (2002). Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int Immunopharmacol 2: 1755-1762.
56. Viswanathan M, Laitinen JT, Saavedra JM (1990). Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci USA 87: 6200-6203.
57. Volonte C, Amadio S, D'Ambrosi N, Colpi M, Burnstock G (2006). P2 receptor web: complexity and fine-tuning. Pharmacol Ther 112: 264-280.
58. Wagner S, Groschner K, Mayer B, Schmidt K (2002). Desensitization of endothelial nitric oxide synthase by receptor agonists. Biochem J 364: 863-868.
59. Ximenes VF, Catalani LH, Campa A (2001). Oxidation of melatonin and tryptofan by an HRP cycle involving compound III. Biochem Biophys Res Commun 287: 130-134.
60. 4-deficient mice. Nat Med 12: 133-137.
61. Yang Q, Scalbert E, Delagrange P, Vanhoutte PM, O'Rourke ST (2001). Melatonin potentiates contractile responses to serotonin in isolated coronary arteries. Am J Physiol 280: H76-H82.